Peptide mass-assisted antibody cloning strategy for accurate characterization of potential therapeutic monoclonal antibodies against neurodegenerative diseases
Sosthène Essono(Commissariat à l'Énergie Atomique et aux Énergies Alternatives), Didier Boquet(Commissariat à l'Énergie Atomique et aux Énergies Alternatives), Gilles Clément(Commissariat à l'Énergie Atomique et aux Énergies Alternatives), Séverine Padiolleau‐Lefèvre(Université de Technologie de Compiègne), Christophe Créminon(Commissariat à l'Énergie Atomique et aux Énergies Alternatives), Jacques Grassi(Universidade Federal do Espírito Santo)
Cited by 4
Related Papers
Enzyme immunoassays of eicosanoids using acetylcholine esterase as label: an alternative to radioimmunoassay
|Analytical Chemistry|1985|707
Cigarette smoke–induced neurogenic inflammation is mediated by α,β-unsaturated aldehydes and the TRPA1 receptor in rodents
|Journal of Clinical Investigation|2008|373
Screening of 145 Anti-PrP Monoclonal Antibodies for Their Capacity to Inhibit PrPSc Replication in Infected Cells
|Journal of Biological Chemistry|2004|330
Demonstration of an inducible cyclooxygenase in human endothelial cells using antibodies raised against the carboxyl-terminal region of the cyclooxygenase-2.
|Journal of Biological Chemistry|1993|289
The mechanism of internalization of glycosylphosphatidylinositol‐anchored prion protein
|The EMBO Journal|2003|282